Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Glial progenitor-based repair of demyelinating neurological diseases.

Keyoung HM, Goldman SA.

Neurosurg Clin N Am. 2007 Jan;18(1):93-104, x. Review.

PMID:
17244557
2.

Progenitor cell-based myelination as a model for cell-based therapy of the central nervous system.

Goldman SA, Lang J, Roy N, Schanz SJ, Sim FS, Wang S, Washco V, Windrem MS.

Ernst Schering Res Found Workshop. 2006;(60):195-213. Review.

PMID:
16903424
3.

Stem cell-based strategies for treating pediatric disorders of myelin.

Goldman SA, Schanz S, Windrem MS.

Hum Mol Genet. 2008 Apr 15;17(R1):R76-83. doi: 10.1093/hmg/ddn052. Review.

PMID:
18632701
4.

Prospects of cell therapy for disorders of myelin.

Ben-Hur T, Goldman SA.

Ann N Y Acad Sci. 2008 Oct;1142:218-49. doi: 10.1196/annals.1444.014. Review.

PMID:
18990129
5.

Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.

Mothe AJ, Tator CH.

Exp Neurol. 2008 Sep;213(1):176-90. doi: 10.1016/j.expneurol.2008.05.024. Epub 2008 Jun 10.

PMID:
18586031
6.

Glial progenitor cell transplantation and the generation of chimeric animal models with human brain cells: implications for novel therapeutics.

Munoz-Sanjuan I.

Expert Opin Ther Pat. 2009 Dec;19(12):1639-46. doi: 10.1517/13543770903443105. Review.

PMID:
19939186
7.

Remyelination: cellular and gene therapy.

Billinghurst LL, Taylor RM, Snyder EY.

Semin Pediatr Neurol. 1998 Sep;5(3):211-28. Review.

PMID:
9777679
8.
9.

Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.

Kulbatski I, Mothe AJ, Parr AM, Kim H, Kang CE, Bozkurt G, Tator CH.

Prog Histochem Cytochem. 2008;43(3):123-76. doi: 10.1016/j.proghi.2008.04.001. Epub 2008 Jun 13. Review.

PMID:
18706353
10.

Stem cells and neurological diseases.

Hess DC, Borlongan CV.

Cell Prolif. 2008 Feb;41 Suppl 1:94-114. doi: 10.1111/j.1365-2184.2008.00486.x. Review.

PMID:
18181951
11.
12.

Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies.

Kondo Y, Duncan ID.

Methods Mol Biol. 2009;549:175-85. doi: 10.1007/978-1-60327-931-4_12.

PMID:
19378203
13.

Cell replacement therapy in neurological disease.

Goldman SA, Windrem MS.

Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1463-75. Review.

14.

Stem cell-based cell therapy for spinal cord injury.

Kim BG, Hwang DH, Lee SI, Kim EJ, Kim SU.

Cell Transplant. 2007;16(4):355-64. Review.

PMID:
17658126
15.

Glial progenitor cell-based treatment of the childhood leukodystrophies.

Osorio MJ, Goldman SA.

Exp Neurol. 2016 Sep;283(Pt B):476-88. doi: 10.1016/j.expneurol.2016.05.010. Epub 2016 May 8. Review.

16.
17.

The potential use of stem cells in multiple sclerosis: an overview of the preclinical experience.

Karussis D, Kassis I.

Clin Neurol Neurosurg. 2008 Nov;110(9):889-96. doi: 10.1016/j.clineuro.2008.02.008. Epub 2008 Mar 28. Review.

PMID:
18375051
18.

Invivo insulin deficiency as a potential etiology for demyelinating disease.

Gong X, Xie Z, Zuo H.

Med Hypotheses. 2008 Sep;71(3):399-403. doi: 10.1016/j.mehy.2008.04.006. Epub 2008 Jul 14.

PMID:
18621485
19.

Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction.

Eftekharpour E, Karimi-Abdolrezaee S, Wang J, El Beheiry H, Morshead C, Fehlings MG.

J Neurosci. 2007 Mar 28;27(13):3416-28.

20.

Combined transplantation of neural stem cells and olfactory ensheathing cells for the repair of spinal cord injuries.

Ao Q, Wang AJ, Chen GQ, Wang SJ, Zuo HC, Zhang XF.

Med Hypotheses. 2007;69(6):1234-7. Epub 2007 Jun 4.

PMID:
17548168

Supplemental Content

Support Center